Literature DB >> 21890419

Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait.

Michael R Johnson1, Simon D Shorvon.   

Abstract

The genetic bases of common, nonmendelian epilepsy have been difficult to elucidate. In this article, we argue for a new approach to genetic inquiry in epilepsy. In the latter part of the 19th century, epilepsy was universally acknowledged to be part of a wider "neurological trait" that included other neuropsychiatric conditions. In recent years, studies of comorbidity have shown clear links between epilepsy and various neuropsychiatric disorders including psychosis and depression, and genetic studies of copy number variants (CNVs) have shown that in some cases, the same CNV underpins neuropsychiatric illness and epilepsy. Functional annotation analysis of the sets of genes impacted by epilepsy CNVs shows enrichment for genes involved with neural development, with gene ontological (GO) categories including "neurological system process" (P=0.006), "synaptic transmission" (P=0.009), and "learning or memory" (P=0.01). These data support the view that epilepsy and some neuropsychiatric conditions share pathogenic neurodevelopmental pathways, and that epilepsy should be included in the spectrum of neurodevelopmental disorders. Yet, most current genetic research in epilepsy has restricted samples to specific types of epilepsy categorized according to the clinical classification schemes on the basis of seizure type, anatomical location, or epilepsy syndrome. These schemes are, to an extent, arbitrary and do not necessarily align with biological reality. We propose an alternative approach that makes no phenotypic assumptions beyond including epilepsy in the neurodevelopmental spectrum. A "'value-free" strategy of reverse phenotyping may be worth exploring, starting with genetic association and looking backward at the phenotype. Finally, it should be noted that there are societal implications to associating epilepsy with other neuropsychiatric disorders, and it is vital to ensure research in this area does not result in increased stigma for patients with epilepsy. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21890419     DOI: 10.1016/j.yebeh.2011.07.031

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  10 in total

Review 1.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

2.  Evidence for a shared genetic susceptibility to migraine and epilepsy.

Authors:  Melodie R Winawer; Robert Connors
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

3.  Familial aggregation of focal seizure semiology in the Epilepsy Phenome/Genome Project.

Authors:  Steven Tobochnik; Robyn Fahlstrom; Catherine Shain; Melodie R Winawer
Journal:  Neurology       Date:  2017-05-31       Impact factor: 9.910

4.  Impaired D-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy.

Authors:  Katharina Klatte; Timo Kirschstein; David Otte; Leonie Pothmann; Lorenz Müller; Tursonjan Tokay; Maria Kober; Mischa Uebachs; Andreas Zimmer; Heinz Beck
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

Review 5.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.

Authors:  Andres Moreno-De-Luca; Scott M Myers; Thomas D Challman; Daniel Moreno-De-Luca; David W Evans; David H Ledbetter
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182

6.  Epilepsy and other seizure disorders in acute psychiatric inpatients.

Authors:  Eylert Brodtkorb; Sverre Georg Sæther; Erlend Iversen Nakken; Frithjof Grinde; Arne Vaaler; Ole Kristian Drange
Journal:  BMC Psychiatry       Date:  2021-12-15       Impact factor: 3.630

7.  Maternal Folate Status and the Relation between Gestational Arsenic Exposure and Child Health Outcomes.

Authors:  Marisa A Patti; Karl T Kelsey; Amanda J MacFarlane; George D Papandonatos; Tye E Arbuckle; Jillian Ashley-Martin; Mandy Fisher; William D Fraser; Bruce P Lanphear; Gina Muckle; Joseph M Braun
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

8.  Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk?

Authors:  Claire Amiet; Isabelle Gourfinkel-An; Claudine Laurent; Nicolas Bodeau; Bérengère Génin; Eric Leguern; Sylvie Tordjman; David Cohen
Journal:  Mol Autism       Date:  2013-12-01       Impact factor: 7.509

9.  Synergistic association of STX1A and VAMP2 with cryptogenic epilepsy in North Indian population.

Authors:  Ruchi Baghel; Sandeep Grover; Harpreet Kaur; Ajay Jajodia; Shama Parween; Juhi Sinha; Ankit Srivastava; Achal Kumar Srivastava; Kiran Bala; Puneet Chandna; Suman Kushwaha; Rachna Agarwal; Ritushree Kukreti
Journal:  Brain Behav       Date:  2016-06-14       Impact factor: 2.708

Review 10.  Cognitive Function in Genetic Generalized Epilepsies: Insights From Neuropsychology and Neuroimaging.

Authors:  Corey Ratcliffe; Britta Wandschneider; Sallie Baxendale; Pamela Thompson; Matthias J Koepp; Lorenzo Caciagli
Journal:  Front Neurol       Date:  2020-03-10       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.